Related references
Note: Only part of the references are listed.Global Levels of Histone Modifications Predict Prognosis in Different Cancers
David B. Seligson et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Epigenetic Changes in Cancer
Christine A. Iacobuzio-Donahue
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Seed in soil, with an epigenetic view
Huey-Jen L. Lin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
Global DNA hypomethylation suppresses squamous carcinogenesis in the tongue and esophagus
Seiji Baba et al.
CANCER SCIENCE (2009)
Let-7 and miR-200 microRNAs Guardians against pluripotency and cancer progression
Marcus E. Peter
CELL CYCLE (2009)
Targeting DNA Methylation
Jean-Pierre J. Issa et al.
CLINICAL CANCER RESEARCH (2009)
Rational Combinations Using HDAC Inhibitors
Michael Bots et al.
CLINICAL CANCER RESEARCH (2009)
Cancer DNA Methylation: Molecular Mechanisms and Clinical Implications
Michael T. McCabe et al.
CLINICAL CANCER RESEARCH (2009)
DNA methylation and cancer diagnosis: new methods and applications
Pierre Dehan et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2009)
Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS
Marta Barradas et al.
GENES & DEVELOPMENT (2009)
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer
Peter Olson et al.
GENES & DEVELOPMENT (2009)
MicroRNAs: tools for cancer diagnostics
T. Paranjape et al.
GUT (2009)
Epigenomic profiling of cancer cells
Gaetano Gargiulo et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
MicroRNAs in clinical oncology: at the crossroads between promises and problems
S. M. Metias et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer
Shundong Cang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2009)
Epigenetics in cancer: Targeting chromatin modifications
Leigh Ellis et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
Epigenetic mechanisms in the biology of prostate cancer
Wolfgang A. Schulz et al.
SEMINARS IN CANCER BIOLOGY (2009)
Epigenetic Cross-Talk between DNA Methylation and Histone Modifications in Human Cancers
Yutaka Kondo
YONSEI MEDICAL JOURNAL (2009)
MicroRNAs - the micro steering wheel of tumour metastases
Milena S. Nicoloso et al.
NATURE REVIEWS CANCER (2009)
Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin?
T. Clouaire et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
MiRNAs, epigenetics, and cancer
Arefeh Rouhi et al.
MAMMALIAN GENOME (2008)
Combinatorial patterns of histone acetylations and methylations in the human genome
Zhibin Wang et al.
NATURE GENETICS (2008)
Molecular Origins of Cancer Molecular Basis of Metastasis
Anne C. Chiang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Models, mechanisms and clinical evidence for cancer dormancy
Julio A. Aguirre-Ghiso
NATURE REVIEWS CANCER (2007)
Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy
Yeonjoo Jung et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Genetic determinants of cancer metastasis
Don X. Nguyen et al.
NATURE REVIEWS GENETICS (2007)
Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis
Susan J. Clark
HUMAN MOLECULAR GENETICS (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Histone deacetylase inhibitors in cancer treatment:: A review of the clinical toxicity and the modulation of gene expression in cancer cells
O. Bruserud et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2007)
Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer
L. G. Wang et al.
MOLECULAR CARCINOGENESIS (2007)
Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors
Zdenko Herceg
MUTAGENESIS (2007)
Cancer metastasis:: Building a framework
Gaorav P. Gupta et al.
CELL (2006)
Epigenetic aberrations and cancer
Miryam Ducasse et al.
MOLECULAR CANCER (2006)
Histone deacetylases as targets for dietary cancer preventive agents: Lessons learned with butyrate, diallyl disulfide, and sulforaphane
MC Myzak et al.
CURRENT DRUG TARGETS (2006)
The epigenetic progenitor origin of human cancer
AP Feinberg et al.
NATURE REVIEWS GENETICS (2006)
DNA methyltransferase inhibitors and the development of epigenetic cancer therapies
F Lyko et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Distinct epigenetic changes in the stromal cells of breast cancers
M Hu et al.
NATURE GENETICS (2005)
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
MF Fraga et al.
NATURE GENETICS (2005)
Calorie restriction -: the SIR2 connection
L Guarente et al.
CELL (2005)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Epigenetic gene silencing in acute promyelocytic leukemia
R Villa et al.
BIOCHEMICAL PHARMACOLOGY (2004)
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Heterochromatin and epigenetic control of gene expression
SIS Grewal et al.
SCIENCE (2003)
Dnmt3L is a transcriptional repressor that recruits histone deacetylase
R Deplus et al.
NUCLEIC ACIDS RESEARCH (2002)
DNA methylation, imprinting and cancer
C Plass et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2002)
Epigenetic reprogramming in mammalian development
W Reik et al.
SCIENCE (2001)